“When you arrive at a diagnosis of non-radiographic axial spondyloarthritis (nr-axSpA), there’s a sense of relief that on one hand you have found the source of your patient’s symptoms. However until recently, we’ve had no specific subsidised treatments. Now we have access to a PBS-listed TNF-inhibitor for patients with nr-axSpA.1 What we’re hoping to see ...
The early bird catches nr-axSpA, but shouldn’t manage the condition alone
31 Mar 2020
Sponsored by Janssen-Cilag Pty Ltd